Skip to content

Clinical trials

Phase 4 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 4 Clear all

127 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20032
20042
20055
20065
20074
20083
20094
201011
20119
20121
20137
20144
20157
20168
20175
20182
20197
20202
20215
20227
20237
20245
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Unknown status26
Terminated9
Recruiting9
Not yet recruiting7
Active, not recruiting4
Enrolling by invitation3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute4
Eisai Inc.3
Emory University3
University of Maryland, Baltimore3
University of Pennsylvania3
Beni-Suef University2
Charite University, Berlin, Germany2
Chinese University of Hong Kong2
Dongzhimen Hospital, Beijing2
Duke University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction127
Dementia18
Alzheimer Disease13
Delirium11
Schizophrenia8
Bipolar Disorder5
Major Depressive Disorder5
Cognition Disorders4
Parkinson Disease4
Psychotic Disorders4

Trials

Showing 51 to 75 of 127. Each trial links to its page on Pharma Observatory.

27 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.